These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34746146)

  • 1. Periphery Biomarkers for Objective Diagnosis of Cognitive Decline in Type 2 Diabetes Patients.
    Liu Y; Zhang S; He B; Chen L; Ke D; Zhao S; Zhang Y; Wei W; Xu Z; Xu Z; Yin Y; Mo W; Li Y; Gao Y; Li S; Wang W; Yu H; Wu D; Pi G; Jiang T; Deng M; Xiong R; Lei H; Tian N; He T; Sun F; Zhou Q; Wang X; Ye J; Li M; Hu N; Song G; Peng W; Zheng C; Zhang H; Wang JZ
    Front Cell Dev Biol; 2021; 9():752753. PubMed ID: 34746146
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients.
    Yu H; Liu Y; He T; Zhang Y; He J; Li M; Jiang B; Gao Y; Chen C; Ke D; Liu J; He B; Yang X; Wang JZ
    Aging Cell; 2021 Oct; 20(10):e13469. PubMed ID: 34528736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-3β activation mediates apolipoprotein E4-associated cognitive impairment in type 2 diabetes mellitus: A multicenter, cross-sectional study.
    Gao Y; Yu H; Liu Y; Xu Z; He B; Liu H; Wang Y; Zhang Y; Liang Y; Yang Y; Zheng J; Wang JZ
    J Diabetes; 2024 Jan; 16(1):e13470. PubMed ID: 37700547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of glycogen synthase kinase-3β with cognitive impairment in type 2 diabetes patients: a six-year follow-up study.
    Wei W; Xu P; Li L; Mao H; Li N; Wang XQ; Wang L; Xu ZP; Zhao S
    Front Endocrinol (Lausanne); 2024; 15():1386773. PubMed ID: 38660514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering new peripheral plasma biomarkers to identify cognitive decline in type 2 diabetes.
    Yu H; Gao Y; He T; Li M; Zhang Y; Zheng J; Jiang B; Chen C; Ke D; Liu Y; Wang JZ
    Front Cell Dev Biol; 2022; 10():818141. PubMed ID: 36506101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periphery Biomarkers Predicting Conversion of Type 2 Diabetes to Pre-Alzheimer-Like Cognitive Decline: A Multicenter Follow-Up Study.
    Liu Y; He B; Du K; Zheng J; Ke D; Mo W; Li Y; Jiang T; Xiong R; Sun F; Zhao S; Wei W; Xu Z; Zhang S; Li S; Wang X; Zhou Q; Ye J; Liang Y; Lin H; Liu Y; Chen L; Zhang H; Zhang Y; Gao Y; Wang JZ
    J Alzheimers Dis; 2024; 100(s1):S115-S129. PubMed ID: 39058442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
    Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
    Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
    Hanon O; Vidal JS; Lehmann S; Bombois S; Allinquant B; Tréluyer JM; Gelé P; Delmaire C; Blanc F; Mangin JF; Buée L; Touchon J; Hugon J; Vellas B; Galbrun E; Benetos A; Berrut G; Paillaud E; Wallon D; Castelnovo G; Volpe-Gillot L; Paccalin M; Robert PH; Godefroy O; Dantoine T; Camus V; Belmin J; Vandel P; Novella JL; Duron E; Rigaud AS; Schraen-Maschke S; Gabelle A;
    Alzheimers Dement; 2018 Jul; 14(7):858-868. PubMed ID: 29458036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.
    Kleinschmidt M; Schoenfeld R; Göttlich C; Bittner D; Metzner JE; Leplow B; Demuth HU
    J Alzheimers Dis; 2016; 50(1):111-26. PubMed ID: 26639953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.
    Parnetti L; Chiasserini D; Eusebi P; Giannandrea D; Bellomo G; De Carlo C; Padiglioni C; Mastrocola S; Lisetti V; Calabresi P
    J Alzheimers Dis; 2012; 29(1):229-38. PubMed ID: 22232006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship Between Plasma Aβ Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.
    Poljak A; Crawford JD; Smythe GA; Brodaty H; Slavin MJ; Kochan NA; Trollor JN; Wen W; Mather KA; Assareh AA; Ng PC; Sachdev PS
    Curr Alzheimer Res; 2016; 13(3):243-55. PubMed ID: 26679856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer's disease.
    Lin SY; Lin KJ; Lin PC; Huang CC; Chang CC; Lee YC; Hsiao IT; Yen TC; Huang WS; Yang BH; Wang PN
    Alzheimers Res Ther; 2019 Dec; 11(1):111. PubMed ID: 31881963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.
    Chiasserini D; Biscetti L; Farotti L; Eusebi P; Salvadori N; Lisetti V; Baschieri F; Chipi E; Frattini G; Stoops E; Vanderstichele H; Calabresi P; Parnetti L
    J Alzheimers Dis; 2016 Jul; 54(1):55-67. PubMed ID: 27447425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer's disease.
    Li W; Wang T; Xiao S
    Neuropsychiatr Dis Treat; 2016; 12():2489-2495. PubMed ID: 27729793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-aβ Peptide in olfactory mucosa and mesenchymal stromal cells of mild cognitive impairment and Alzheimer's disease patients.
    Ayala-Grosso CA; Pieruzzini R; Diaz-Solano D; Wittig O; Abrante L; Vargas L; Cardier J
    Brain Pathol; 2015 Mar; 25(2):136-45. PubMed ID: 25040401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory dysfunction is a risk factor for the comorbidity of mild cognitive impairment and Type 2 diabetes mellitus.
    Gong L; Xie J; Liu J; Tang G; Lin W; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):831-837. PubMed ID: 34565726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.